PROX1 gene CC genotype as a major determinant of early onset of type 2 diabetes in slavic study participants from Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation study.
<p>Background: The prevalence of diabetic nephropathy varies according to ethnicity. Environmental as well as genetic factors contribute to the heterogeneity in the presentation of diabetic nephropathy. Our objective was to evaluate this heterogeneity within the Caucasian population.</p>...
Main Authors: | Hamet, P, Haloui, M, Harvey, F, Marois-Blanchet, F, Sylvestre, M, Tahir, M, Simon, P, Kanzki, B, Raelson, J, Long, C, Chalmers, J, Woodward, M, Marre, M, Harrap, S, Tremblay, J |
---|---|
Format: | Journal article |
Published: |
Lippincott, Williams & Wilkins
2017
|
Similar Items
-
Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
by: van Steen, S, et al.
Published: (2018) -
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
by: ADVANCE Management Committee
Published: (2001) -
EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes
by: Zhang, Z, et al.
Published: (2019) -
Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene
by: Tremblay, J, et al.
Published: (2017) -
Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
by: Rådholm, K, et al.
Published: (2018)